{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:44:48Z","timestamp":1790390688568,"version":"4.1.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Background: Accumulating evidence links higher circulating asymmetric dimethylarginine (ADMA) to greater risk of cardiovascular disease (CVD). Relatively small differences in ADMA concentrations between healthy individuals and those with disease underscore the need to formulate reference intervals that may aid risk stratification of individuals.<\/jats:p><jats:p>Methods: We formulated reference intervals for plasma ADMA concentrations using a community-based reference sample from the Framingham Offspring Study consisting of 1126 nonsmoking individuals [mean (SD) age 56 (9) years; 60% women] who were free of clinical CVD, hypertension, diabetes, and obesity and who attended a routine examination at which ADMA was assayed. ADMA concentrations were determined using a validated tandem mass spectrometry\u2013liquid chromatography assay.<\/jats:p><jats:p>Results: In the study sample, the mean ADMA concentration was 0.52 (0.11) \u03bcmol\/L, and the reference limits were 0.311 and 0.732 (2.5th and 97.5th percentile). The sex-specific reference limits were 0.310 and 0.745 in men and 0.313 and 0.721 \u03bcmol\/L in women. In multivariable regression analysis, ADMA plasma concentrations were positively correlated with age and total plasma homocysteine (both P &amp;lt; 0.001).<\/jats:p><jats:p>Conclusions: Reference limits calculated for circulating ADMA in our large community-based healthy reference sample confirm the previous observation of a relatively narrow distribution of concentrations. This suggests a tight physiological control of ADMA plasma concentrations, presumably by dimethylarginine dimethylaminohydrolase (DDAH) metabolism of ADMA.<\/jats:p>","DOI":"10.1373\/clinchem.2009.124263","type":"journal-article","created":{"date-parts":[[2009,6,19]],"date-time":"2009-06-19T01:52:26Z","timestamp":1245376346000},"page":"1539-1545","source":"Crossref","is-referenced-by-count":55,"title":["Asymmetric Dimethylarginine Reference Intervals Determined with Liquid Chromatography\u2013Tandem Mass Spectrometry: Results from the Framingham Offspring Cohort"],"prefix":"10.1093","volume":"55","author":[{"given":"Edzard","family":"Schwedhelm","sequence":"first","affiliation":[{"name":"Clinical Pharmacology Unit, Institute of Experimental and Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Xanthakis","sequence":"first","affiliation":[{"name":"Department of Biostatistics, Boston University School of Public Health, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renke","family":"Maas","sequence":"first","affiliation":[{"name":"Clinical Pharmacology Unit, Institute of Experimental and Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"},{"name":"Institute of Experimental and Clinical Pharmacology and Toxicology, University of Erlangen, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M","family":"Sullivan","sequence":"first","affiliation":[{"name":"Department of Biostatistics, Boston University School of Public Health, Boston, MA"},{"name":"Framingham Heart Study, Framingham, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Schulze","sequence":"first","affiliation":[{"name":"Clinical Pharmacology Unit, Institute of Experimental and Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Riederer","sequence":"first","affiliation":[{"name":"Institute of Pharmacy, University of Hamburg, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf A","family":"Benndorf","sequence":"first","affiliation":[{"name":"Clinical Pharmacology Unit, Institute of Experimental and Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer H","family":"Bo\u0308ger","sequence":"first","affiliation":[{"name":"Clinical Pharmacology Unit, Institute of Experimental and Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramachandran S","family":"Vasan","sequence":"first","affiliation":[{"name":"Framingham Heart Study, Framingham, MA"},{"name":"Preventive Medicine and Cardiology Sections, Department of Medicine, Boston University School of Medicine, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,8,1]]},"reference":[{"key":"2020022800330658800_R1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/07853890500472151","volume":"38","year":"2006","journal-title":"Ann Med"},{"key":"2020022800330658800_R2","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.CIR.98.18.1842","volume":"98","year":"1998","journal-title":"Circulation"},{"key":"2020022800330658800_R3","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1161\/CIRCULATIONAHA.107.690016","volume":"116","year":"2007","journal-title":"Circulation"},{"key":"2020022800330658800_R4","first-page":"1685","year":"2005","journal-title":"N Engl J Med"},{"key":"2020022800330658800_R5","doi-asserted-by":"crossref","first-page":"493.e1","DOI":"10.1016\/j.ahj.2006.06.005","volume":"152","year":"2006","journal-title":"Am Heart J"},{"key":"2020022800330658800_R6","first-page":"2127","volume":"358","year":"200","journal-title":"Lancet"},{"key":"2020022800330658800_R7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1373\/clinchem.2006.081893","volume":"53","year":"2007","journal-title":"Clin Chem"},{"key":"2020022800330658800_R8","first-page":"e53","year":"2005","journal-title":"Circ Res"},{"key":"2020022800330658800_R9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1373\/clinchem.2006.076711","volume":"53","year":"2007","journal-title":"Clin Chem"},{"key":"2020022800330658800_R10","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1161\/CIRCULATIONAHA.108.838268","volume":"119","year":"2009","journal-title":"Circulation"},{"key":"2020022800330658800_R11","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1373\/clinchem.2004.046037","volume":"51","year":"2005","journal-title":"Clin Chem"},{"key":"2020022800330658800_R12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jchromb.2006.11.052","volume":"851","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2020022800330658800_R13","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2105\/AJPH.49.10.1349","volume":"49","year":"1959","journal-title":"Am J Public Health Nations Health"},{"key":"2020022800330658800_R14","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1373\/clinchem.2005.058339","volume":"51","year":"2005","journal-title":"Clin Chem"},{"key":"2020022800330658800_R15","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/jama.288.10.1252","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"2020022800330658800_R16","year":"1987","journal-title":"The Framingham Study: an epidemiological investigation of cardiovascular disease. Section 34. Some risk factors related to the annual incidence of cardiovascular disease and death in pooled repeated biennial measurements: Framingham Heart Study, 30-year follow-up"},{"key":"2020022800330658800_R17","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1161\/01.CIR.0000057810.48709.F6","volume":"107","year":"2003","journal-title":"Circulation"},{"key":"2020022800330658800_R18","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.289.10.1251","volume":"289","year":"2003","journal-title":"JAMA"},{"key":"2020022800330658800_R19","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/0009-8981(87)90151-3","volume":"170","year":"1987","journal-title":"Clin Chim Acta"},{"key":"2020022800330658800_R20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ps.1145","volume":"62","year":"2006","journal-title":"Pest Manag Sci"},{"key":"2020022800330658800_R21","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/clinchem\/44.3.622","volume":"44","year":"1998","journal-title":"Clin Chem"},{"key":"2020022800330658800_R22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jchromb.2006.07.024","volume":"851","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2020022800330658800_R23","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1161\/01.CIR.0000101924.04515.2E","volume":"108","year":"2003","journal-title":"Circulation"},{"key":"2020022800330658800_R24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm1543","volume":"13","year":"2007","journal-title":"Nat Med"},{"key":"2020022800330658800_R25","doi-asserted-by":"crossref","first-page":"H3227","DOI":"10.1152\/ajpheart.00998.2007","volume":"293","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2020022800330658800_R26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cca.2007.07.006","volume":"384","year":"2007","journal-title":"Clin Chim Acta"},{"key":"2020022800330658800_R27","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2362.2005.01561.x","volume":"35","year":"2005","journal-title":"Eur J Clin Invest"},{"key":"2020022800330658800_R28","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1080\/00365510701429836","volume":"67","year":"2007","journal-title":"Scand J Clin Lab Invest"},{"key":"2020022800330658800_R29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/CS20020309","volume":"105","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"2020022800330658800_R30","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1210\/jc.2003-030584","volume":"88","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020022800330658800_R31","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1161\/01.CIR.0000091083.61609.DF","volume":"108","year":"2003","journal-title":"Circulation"},{"key":"2020022800330658800_R32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.atherosclerosis.2005.05.002","volume":"184","year":"2006","journal-title":"Atherosclerosis"},{"key":"2020022800330658800_R33","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/01.CIR.0000085067.55901.89","volume":"108","year":"2003","journal-title":"Circulation"},{"key":"2020022800330658800_R34","first-page":"2569","volume":"104","year":"2002","journal-title":"Circulation"},{"key":"2020022800330658800_R35","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.atherosclerosis.2006.06.007","volume":"193","year":"2007","journal-title":"Atherosclerosis"},{"key":"2020022800330658800_R36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.atherosclerosis.2004.06.003","volume":"176","year":"2004","journal-title":"Atherosclerosis"},{"key":"2020022800330658800_R37","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.atherosclerosis.2006.03.022","volume":"191","year":"2007","journal-title":"Atherosclerosis"},{"key":"2020022800330658800_R38","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1111\/j.1523-1755.2005.00680.x","volume":"68","year":"2005","journal-title":"Kidney Int"},{"key":"2020022800330658800_R39","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"2020022800330658800_R40","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1681\/ASN.V131170","volume":"13","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"2020022800330658800_R41","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jacc.2005.04.040","volume":"46","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2020022800330658800_R42","first-page":"S45","volume":"10 Suppl 1","year":"2005","journal-title":"Vasc Med"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/55\/8\/1539\/32675952\/clinchem1539.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/55\/8\/1539\/32675952\/clinchem1539.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T15:12:31Z","timestamp":1633619551000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/55\/8\/1539\/5629212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,1]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2009,8,1]]},"published-print":{"date-parts":[[2009,8,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2009.124263","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2009,8,1]]},"published":{"date-parts":[[2009,8,1]]}}}